NPR

Prices For COVID-19 Vaccines Are Starting To Come Into Focus

Moderna, one of the leading horses in the coronavirus vaccine race, has already made deals at between $32 and $37 a dose for some foreign countries. The U.S. price is expected to be lower.
Tony Potts, 69, a retiree from Ormond Beach, Fla., receives his first Moderna COVID-19 vaccine shot Tuesday as part of the company's phase three clinical trial.

How much will vaccines against the coronavirus cost? Even though none has finished clinical testing, some clues about pricing are starting to emerge.

Cambridge, Mass.-based Moderna, one of the leading horses in the vaccine race, has already made deals at between $32 and $37 per dose of its experimental coronavirus vaccine in agreements with some foreign countries, rattling consumer advocates, who fear an unfair deal for U.S. taxpayers.

These Moderna prices reflected "smaller volume agreements," Moderna CEO StĂŠphaneBancel said during aWednesday to discuss the company's second-quarter financial results. He added that the price would come down for larger volume agreements, hinting

You’re reading a preview, subscribe to read more.

More from NPR

NPR4 min read
From Pandemic To Protests, The Class Of 2024 Has Been Through A Lot
Pomp and circumstance again fall victim to circumstance for some students in the graduating class of 2024, as protests over the war in Gaza threaten to disrupt commencement ceremonies.
NPR2 min read
Short-term Loss For Long-term Gain? The Ethical Dilemma At The Heart Of EVs
As mines meet mineral demands for electric vehicles, they put communities and ecosystems at risk. Sustainability researcher Elsa Dominish says the EV industry cannot repeat fossil fuel's mistakes.
NPR4 min read
Yes, Apple's New IPad Ad Is Ugly And Crushing, But Art Can't Be Flattened
The newest iPad ad depicts instruments, books and art supplies flattened into Apple's thinnest product ever. But anyone who owns and loves art in any form knows: The practicality isn't the point.

Related Books & Audiobooks